Metabolism in vitro of sulindac. Sulfoxide-reducing enzyme systems in guinea pig liver.
- 1 January 1980
- journal article
- research article
- Published by Pharmaceutical Society of Japan in Journal of Pharmacobio-Dynamics
- Vol. 3 (6) , 290-298
- https://doi.org/10.1248/bpb1978.3.290
Abstract
The sulfoxide reduction of sulindac (cis-5-fluoro-2-methyl-1-[p-(methylsulfinyl)-benzylidenyl] indene-3-acetic acid), an anti-inflammatory agent, was demonstrated in vitro by cell-free preparations of guinea pig liver. The sulfoxide reductase activity was located in both fractions of microsomes and 105000×g supernatant. The microsomal reductase was NADPH-or NADH-dependent, and required the factor present in the soluble fraction for its activity. The factor was heat-labile and non-dialyzable. Furthermore, a pattial purification of the microsomal NADPH-cytochrome c reductase resulted in a paralleled increase of the sulfoxide reductase activity. The present observations suggest that the soluble factor described above functions as an electron transfer component coupled with NADPH-cytochrome c reductase.Keywords
This publication has 6 references indexed in Scilit:
- Enzymatic Reduction of Methionine Sulfoxide.In VitroExperiments with Rat Liver and KidneyAgricultural and Biological Chemistry, 1979
- Comparative disposition of sulindac and metabolites in five speciesBiochemical Pharmacology, 1978
- Purification and properties of a soluble protein activator of rat liver squalene epoxidase.Journal of Biological Chemistry, 1977
- The disposition of sulindacClinical Pharmacology & Therapeutics, 1977
- IDENTIFICATION OF BIOLOGICALLY-ACTIVE FORM OF SULINDAC1977
- HYDROXYLATION OF STEROIDS AT CARBON 21Journal of Biological Chemistry, 1957